| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharma | Pharmaceuticals& Drugs | 829.7 |
-4.95 (-0.59%) |
Small Cap | 7,345 | 35.3 | 9.29 | 23.7 | 2.8 | |
| Piramal Pharma | Pharmaceuticals& Drugs | 209.4 |
1.1 (0.53%) |
Small Cap | 4,782 | 5.3 | 10.29 | 39.6 | 3.4 | |
| Gland Pharma | Pharmaceuticals& Drugs | 2,600.5 |
-17.05 (-0.65%) |
Small Cap | 4,552 | 78.8 | 27.53 | 33.2 | 4 | |
| Natco Pharma | Pharmaceuticals& Drugs | 917.2 |
4.8 (0.53%) |
Small Cap | 4,430 | 79.2 | 40.5 | 11.5 | 1.8 | |
| Emcure Pharma | Pharmaceuticals& Drugs | 1,977.1 |
41 (2.12%) |
Small Cap | 4,382 | 42.7 | 6.24 | 45.3 | 9.9 | |
| Granules India | Pharmaceuticals& Drugs | 872.5 |
34.25 (4.09%) |
Small Cap | 3,474 | 16.3 | 11.88 | 51.6 | 5.1 | |
| Viyash Scientific | Pharmaceuticals& Drugs | 277.1 |
4.2 (1.54%) |
Small Cap | 3,420 | 4 | 7.13 | 67.6 | 4.4 | |
| Wockhardt | Pharmaceuticals& Drugs | 2,020.7 |
47.7 (2.42%) |
Small Cap | 3,373 | 13.1 | 6.07 | 150.5 | 6.5 | |
| Global Health | Hospital &HealthcareServices | 1,455 |
14.9 (1.03%) |
Small Cap | 3,204 | 17.9 | 15.48 | 80.4 | 9.3 | |
| Manipal Health Enter | Hospital &HealthcareServices | 677.4 |
26.05 (4%) |
Small Cap | 3,104 | 4.1 | 17.18 | 160.1 | 5.7 | |
| Eris Lifesciences | Pharmaceuticals& Drugs | 1,384 |
-5.45 (-0.39%) |
Small Cap | 2,894 | 46.5 | 12.9 | 29.9 | 4.8 | |
| Dishman Carbogen Amc | Pharmaceuticals& Drugs | 193.5 |
-1.1 (-0.57%) |
Small Cap | 2,712 | 6.2 | 0.85 | 31.3 | 0.5 | |
| Dr. Lal Pathlabs | Hospital &HealthcareServices | 1,931.4 |
4.15 (0.22%) |
Small Cap | 2,648 | 32.5 | 19.83 | 59.3 | 12.6 | |
| Pfizer | Pharmaceuticals& Drugs | 4,865.1 |
-36.25 (-0.74%) |
Small Cap | 2,520 | 160.7 | 30.02 | 30.5 | 5.1 | |
| Aarti Drugs | Pharmaceuticals& Drugs | 416.4 |
5.4 (1.31%) |
Small Cap | 2,387 | 21 | 7.04 | 19.6 | 2.4 | |
| Alivus Life Sciences | Pharmaceuticals& Drugs | 1,328.3 |
6.9 (0.52%) |
Small Cap | 2,387 | 49.1 | 20.07 | 26.9 | 4.7 | |
| Astrazeneca Pharma | Pharmaceuticals& Drugs | 8,188.2 |
96.8 (1.2%) |
Small Cap | 2,276 | 75 | 8.39 | 107.9 | 23.4 | |
| Strides Pharma Scien | Pharmaceuticals& Drugs | 1,007.1 |
11.45 (1.15%) |
Small Cap | 2,180 | 26.4 | 2.53 | 37.7 | 2.7 | |
| IOL Chem & Pharma | Pharmaceuticals& Drugs | 167.8 |
4.65 (2.85%) |
Small Cap | 2,079 | 4.7 | 4.59 | 34.8 | 2.7 | |
| FDC | Pharmaceuticals& Drugs | 370.2 |
0 (0%) |
Small Cap | 2,070 | 18.2 | 12.16 | 20.4 | 2.3 | |
| Neuland Laboratories | Pharmaceuticals& Drugs | 22,843.6 |
1343.6 (6.25%) |
Small Cap | 2,023 | 387.2 | 17.77 | 55.5 | 13.7 | |
| Caplin Point Labs. | Pharmaceuticals& Drugs | 2,575.1 |
-9.5 (-0.37%) |
Small Cap | 1,937 | 84.4 | 27.17 | 30.6 | 5.5 | |
| Hikal | Pharmaceuticals& Drugs | 227.1 |
4.7 (2.11%) |
Small Cap | 1,860 | -2.7 | 4.72 | - | 2.3 | |
| Sanofi India | Pharmaceuticals& Drugs | 3,345.5 |
-5.65 (-0.17%) |
Small Cap | 1,837 | 140.6 | 18.75 | 23.8 | 9.3 | |
| Aarti Pharmalabs | Pharmaceuticals& Drugs | 684.6 |
-5.05 (-0.73%) |
Small Cap | 1,771 | 19.4 | 14.41 | 35.5 | 3.2 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: